Monday, September 21, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

GLP-1semaglutidestep upbody compositionobesitynovo nordisk

STEP UP MRI substudy shows semaglutide cuts thigh muscle fat infiltration

In 55 participants with valid scans, adipose tissue fell 11.1 L versus placebo while thigh skeletal muscle volume change was not statistically significant.

MH
By Maren Holt · Senior Reporter, GLP-1
Sep 19 20:00 ETSource: Diabetes, obesity & metabolism

The wire

  1. 01Prespecified secondary analysis of the phase 3b STEP UP trial found treatment differences of -11.1 L adipose tissue, -1.5 L visceral fat and -0.92 percentage points thigh muscle fat infiltration for pooled semaglutide versus placebo at 72 weeks.
  2. 02Sit-to-stand repetitions rose from 13 to 15 in both groups, offering clinicians a counterpoint to concerns that high-dose semaglutide erodes muscle function.
  3. 03Only 55 of 1,407 participants had valid baseline MRI, with just six on placebo and six on 2.4 mg, so the imaging comparison is small and imbalanced; authors call for further research.

From the source

Effect of Semaglutide on Thigh Skeletal Muscle Volume, Fat Infiltration and Physical Function in People With Obesity: Secondary Analysis of STEP UP

Diabetes, obesity & metabolism · 2026 Sep 20 · Hjelmesæth J, Bhat S, Garvey WT et al.

Read at pubmed.ncbi.nlm.nih.gov